XTX Topco Ltd

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 1828301 LONDON, X0

Position in ORMP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$240,129

+$162,990 QoQ

Shares Held

49,923

+120.0% QoQ

Ownership

0.120%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#29

of 84 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $413,155,276 across 381 Biotechnology names. ORMP ranks #225 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$240,129	49,923	+120.0%	Shares	Defined	2026-08-14
2026-03-31	$77,139	22,688	-40.6%	Shares	Defined	2026-05-15
2025-12-31	$108,818	38,182	+59.9%	Shares	Defined	2026-02-17
2025-09-30	$63,056	23,885	-3.4%	Shares	Defined	2025-11-14
2024-09-30	$60,307	24,716	+59.7%	Shares	Defined	2024-11-14
2024-06-30	$39,768	15,474	-10.7%	Shares	Defined	2024-08-12
2023-12-31	$40,020	17,325	-88.6%	Shares	Defined	2024-02-13
2023-03-31	$330,531	151,620	+165.6%	Shares	Defined	2023-05-12
2022-12-31	$686,708	57,083	+214.1%	Shares	Defined	2023-02-14
2022-06-30	$83,236	18,174	+72.2%	Shares	Defined	2022-08-15
2021-12-31	$150,739	10,556	—	Shares	Defined	2022-02-11
No filing history on record for this holder in this stock.